Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jinxin Fertility Group Ltd. ( (HK:1951) ) has provided an update.
Jinxin Fertility Group Ltd. announced a change in its board composition with the resignation of Mr. Fang Min as a non-executive director and his replacement by Mr. Shuyun Chen, effective immediately. Mr. Chen brings extensive experience from his previous roles in investment and healthcare sectors, which could enhance the company’s strategic direction and governance.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.80 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the healthcare industry, focusing on fertility services. The company is involved in providing specialized medical services related to fertility and reproductive health.
Average Trading Volume: 89,960,775
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.71B
For a thorough assessment of 1951 stock, go to TipRanks’ Stock Analysis page.